title: The effect of glucose when added to a fat load on the response of glucagon-like peptide-1 (GLP-1) and apolipoprotein B-48 in the postprandial phase.
abstract: Increased and prolonged postprandial lipemia has been identified as a risk factor of cardiovascular disease. However, there is no consensus on how to test postprandial lipemia, especially with respect to the composition of an experimental meal. To address this question of how glucose, when added to a fat load, affects the selected parameters of postprandial lipemia, we carried out a study in 30 healthy male volunteers. Men consumed an experimental meal containing either 75 g of fat + 25 g of glucose (F+G meal) or 75 g of fat (F meal) in a control experiment. Blood was taken before the meal and at selected time points within the following 8 h. Glucose, when added to a fat load, induced an increase of glycemia and insulinemia and, surprisingly, a 20 % reduction in the response of both total and active glucagon-like peptide-1 (GLP-1) concentration. The addition of glucose did not affect the magnitude of postprandial triglyceridemia and TRL-C and TRL-TG concentrations but stimulated a faster response of chylomicrons to the test meal, evaluated by changes in apolipoprotein B-48 concentrations. The addition of glucose induced the physiological response of insulin and the lower response of GLP-1 to the test meal during the early postprandial phase, but had no effect on changes of TRL-cholesterol and TRL-TG within 8 h after the meal.
authors.affiliation: Laboratory for Atherosclerosis Research, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. katerina.zemankova@ikem.cz.
authors.forename: K
authors.initials: K
authors.lastname: Zemánková
authors.forename: J
authors.initials: J
authors.lastname: Mrázková
authors.forename: J
authors.initials: J
authors.lastname: Piťha
authors.forename: J
authors.initials: J
authors.lastname: Kovář
mesh_terms: D000328:Adult; D053283:Apolipoprotein B-48 / Q000097:blood*; D004041:Dietary Fats / Q000008:administration & dosage*; D052216:Glucagon-Like Peptide 1 / Q000097:blood*; D005947:Glucose / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D019518:Postprandial Period / Q000187:drug effects / Q000502:physiology*
chemical_list: D053283:Apolipoprotein B-48; D004041:Dietary Fats; D052216:Glucagon-Like Peptide 1; D005947:Glucose